Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 129, Issue 10, Pages 4165-4179
Publisher
American Society for Clinical Investigation
Online
2019-07-12
DOI
10.1172/jci127308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo
- (2019) Thiago M. Batista et al. Cell Reports
- ApoC-III ASO Promotes Tissue LPL Activity in Absence of ApoE-Mediated TRL Clearance
- (2019) Bastian Ramms et al. JOURNAL OF LIPID RESEARCH
- Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D
- (2019) Arpita Basu et al. JOURNAL OF LIPID RESEARCH
- Metabolic Karma—The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture
- (2018) Mark Emmanuel Cooper et al. DIABETES
- FoxO transcription factors are required for hepatic HDL cholesterol clearance
- (2018) Samuel X. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
- (2018) Gissette Reyes-Soffer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes
- (2017) Michael J. Kraakman et al. JOURNAL OF CLINICAL INVESTIGATION
- Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL
- (2017) Mikael Larsson et al. JOURNAL OF LIPID RESEARCH
- Inflammatory stimuli induce acyl-CoA thioesterase 7 and remodeling of phospholipids containing unsaturated long (≥C20)-acyl chains in macrophages
- (2017) Valerie Z. Wall et al. JOURNAL OF LIPID RESEARCH
- Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III
- (2017) Raimund Pechlaner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity
- (2017) Danish Saleheen et al. NATURE
- A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
- (2017) Sumeet A Khetarpal et al. NATURE MEDICINE
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
- (2017) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does Elevated Glucose Promote Atherosclerosis? Pros and Cons: Table.
- (2016) Karin E. Bornfeldt CIRCULATION RESEARCH
- Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
- (2016) Manasi S. Shah et al. CIRCULATION RESEARCH
- Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
- (2016) Marja-Riitta Taskinen et al. Current Atherosclerosis Reports
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII
- (2015) Haibo Li et al. CARDIOVASCULAR RESEARCH
- Therapeutic inhibition of apoC-III for the treatment of hypertriglyceridemia
- (2015) Thomas A Bell et al. Clinical Lipidology
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
- (2015) Frank M. Sacks CURRENT OPINION IN LIPIDOLOGY
- Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality
- (2015) Trevor J. Orchard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects
- (2015) Baohai Shao et al. JOURNAL OF PROTEOME RESEARCH
- Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics
- (2015) Graziella E. Ronsein et al. Journal of Proteomics
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin resistance and hyperglycaemia in cardiovascular disease development
- (2014) Markku Laakso et al. Nature Reviews Endocrinology
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis
- (2013) Prabhakara R. Nagareddy et al. Cell Metabolism
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
- (2013) D. M. Nathan et al. DIABETES
- Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
- (2013) John M. Lachin et al. DIABETES CARE
- Cholesterol Efflux
- (2012) Alan R. Tall et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1
- (2012) J. E. Kanter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypercholesterolemia links hematopoiesis with atherosclerosis
- (2012) Oliver Soehnlein et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
- (2010) Sandrine Caron et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- (2010) Brendan MacLean et al. BIOINFORMATICS
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
- (2009) A. Hiukka et al. DIABETES
- Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance
- (2008) Alexander Laatsch et al. ATHEROSCLEROSIS
- Diabetes and atherosclerosis: is there a role for hyperglycemia?
- (2008) Alan Chait et al. JOURNAL OF LIPID RESEARCH
- Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice
- (2008) F. Johansson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation